Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort
- PMID: 29618056
- PMCID: PMC6005016
- DOI: 10.1093/ije/dyy044
Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort
Figures


Similar articles
-
Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts.Int J Epidemiol. 2022 Jun 13;51(3):e87-e94. doi: 10.1093/ije/dyab275. Int J Epidemiol. 2022. PMID: 35134983 Free PMC article. No abstract available.
-
The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research.Br J Haematol. 2010 Mar;148(5):739-53. doi: 10.1111/j.1365-2141.2009.08010.x. Epub 2009 Dec 1. Br J Haematol. 2010. PMID: 19958356 Free PMC article.
-
Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN).Cancer Causes Control. 2016 Aug;27(8):1019-26. doi: 10.1007/s10552-016-0780-z. Epub 2016 Jun 28. Cancer Causes Control. 2016. PMID: 27351920 Free PMC article.
-
Haematological malignancies: the rationale for integrated haematopathology services, key elements of organization and wider contribution to patient care.Histopathology. 2011 Jan;58(1):145-54. doi: 10.1111/j.1365-2559.2010.03697.x. Histopathology. 2011. PMID: 21261689 Review.
-
An experience with sixty cases of haematological malignancies; a clinico haematological correlation.J Ayub Med Coll Abbottabad. 2004 Oct-Dec;16(4):51-4. J Ayub Med Coll Abbottabad. 2004. PMID: 15762065 Review.
Cited by
-
Reframing How Physical Activity Reduces The Incidence of Clinically-Diagnosed Cancers: Appraising Exercise-Induced Immuno-Modulation As An Integral Mechanism.Front Oncol. 2022 Mar 14;12:788113. doi: 10.3389/fonc.2022.788113. eCollection 2022. Front Oncol. 2022. PMID: 35359426 Free PMC article. Review.
-
Monoclonal gammopathy of increasing significance: time to screen?Haematologica. 2023 Jun 1;108(6):1476-1486. doi: 10.3324/haematol.2022.281802. Haematologica. 2023. PMID: 36373250 Free PMC article. Review.
-
Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.Hemasphere. 2023 Apr 5;7(4):e863. doi: 10.1097/HS9.0000000000000863. eCollection 2023 Apr. Hemasphere. 2023. PMID: 37038467 Free PMC article. No abstract available.
-
Still lost in transition: a qualitative descriptive study of people's experiences following treatment completion for haematological cancer in Wales, UK.Ecancermedicalscience. 2019 Dec 12;13:985. doi: 10.3332/ecancer.2019.985. eCollection 2019. Ecancermedicalscience. 2019. PMID: 32010209 Free PMC article.
-
Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts.Int J Epidemiol. 2022 Jun 13;51(3):e87-e94. doi: 10.1093/ije/dyab275. Int J Epidemiol. 2022. PMID: 35134983 Free PMC article. No abstract available.
References
-
- Arber DA, Orazi A, Hasserjian R. et al. The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia. Blood 2016;127:2391–405. - PubMed
-
- Jaffe ES, Harris NL, Stein H, Vardiman JW.. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Oxford, UK: Oxford University Press, 2001.
-
- Swerdlow S, Campo E, Harris NL. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn. Lyon, France: International Agency for Research on Cancer, 2008.
-
- Vardiman JW, Thiele J, Arber DA. et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114:937–51. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources